S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How major US stock indexes fared Thursday, 4/18/2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How major US stock indexes fared Thursday, 4/18/2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How major US stock indexes fared Thursday, 4/18/2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
What's Driving Tesla Lower Ahead of its Earnings?
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
How major US stock indexes fared Thursday, 4/18/2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
NASDAQ:VTL

Vital Therapies (VTL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.21
$1.29
50-Day Range
$0.83
$14.50
52-Week Range
$0.15
$9.75
Volume
191,721 shs
Average Volume
21.62 million shs
Market Capitalization
$51.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VTL stock logo

About Vital Therapies Stock (NASDAQ:VTL)

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

VTL Stock News Headlines

Vital Ltd VTL
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Vital Ltd.
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Best Online Therapy For Anxiety Of 2023
5 Best Online Therapy For Teens Of 2023
Occupational Therapy Assistant
Asthma & COPD Therapies Market Report 2023-2033
Vital Limited (VTL.NZ)
Vital Ltd
See More Headlines
Receive VTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vital Therapies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/07/2018
Today
4/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:VTL
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-41,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.29 per share

Miscellaneous

Free Float
N/A
Market Cap
$51.27 million
Optionable
Not Optionable
Beta
3.51
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Daniel Vitt
    President, Chief Executive Officer & Director
  • Manfred Gröppel
    Chief Operating Officer
  • Glenn Whaley
    VP-Finance, Chief Financial & Accounting Officer
  • Andreas Muehler
    Chief Medical Officer
  • Hella Kohlhof
    Chief Scientific Officer

VTL Stock Analysis - Frequently Asked Questions

How were Vital Therapies' earnings last quarter?

Vital Therapies, Inc. (NASDAQ:VTL) issued its earnings results on Tuesday, August, 7th. The company reported ($0.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.03.

What other stocks do shareholders of Vital Therapies own?
This page (NASDAQ:VTL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners